Pakistan launches Phase III trials for Chinese Cansinobio’s COVID-19 vaccine


Source: yahoo.com yahoo.com

Key Topics in this News Article:

News Snapshot:

By Umar Farooq and Asif Shahzad ISLAMABAD (Reuters) - Pakistan has launched Phase III clinical trials for CanSino Biologics' COVID-19 vaccine candidate, a government minister and an official at the Chinese pharmaceutical company said on Tuesday. Pakistan gave the go-ahead for the country's first Phase-III clinical trial in August for CanSino's candidate, Ad5-nCoV, led by the government-run National Institute of Health (NIH) and pharmaceutical company AJM - the local representative of CanSino. "Just launched the Phase III trials for a COVID-19 vaccine in Pakistan," said the minister for planning, Asad Umar, who also oversees command and control operations headed by...